Research use only · Multi-region fulfillment · Support-assisted ordering
VestaResearch Supply
Planep 50mg Tablets | 105-Count | APIXABAN
Pharma

Planep 50mg Tablets | 105-Count | APIXABAN

$180

In stock

For in vitro laboratory research only. Not for human or veterinary consumption.

India Warehouse APIXABAN — 50mg per tablet, 105-count pack. Stroke prevention in non-valvular atrial fibrillation, DVT/PE treatment and prevention, and post-surgical thromboprophylaxis. Preferred over warfarin for predictable dosing without monitoring. Key warning: Reversal agent available but expensive. Avoid strong CYP3A4/P-gp inhibitors (ketoconazole, ritonavir). Reduce dose in renal impairment. Hold 24–48h before surgery. No routine monitoring required.

SKU
VES-004548-PLANEP-50MG-105TAB
Format
N/A
Use
Laboratory research only
Ask on Telegram

What is Planep 50mg (APIXABAN)?

Stroke prevention in non-valvular atrial fibrillation, DVT/PE treatment and prevention, and post-surgical thromboprophylaxis. Preferred over warfarin for predictable dosing without monitoring.

How it Works

Direct Factor Xa inhibitor — blocks final common pathway of coagulation cascade, preventing thrombin generation and clot formation.

Quick Specs

Form
Oral tablets — pre-dosed
Active Ingredient
APIXABAN
Dose per Tablet
50MG
Pack Size
105 tablets
Storage
Room temperature (15–25°C), cool dry place
Shelf Life
2–3 years (properly stored)

Common Side Effects

Bleeding (primary risk — bruising, GI hemorrhage, intracranial hemorrhage), anemia, nausea. Lower bleeding risk than warfarin in atrial fibrillation.

Safety Warnings

Reversal agent available but expensive. Avoid strong CYP3A4/P-gp inhibitors (ketoconazole, ritonavir). Reduce dose in renal impairment. Hold 24–48h before surgery. No routine monitoring required. International shipping: 7–14 days

Research use only

This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.